Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double‐blind, randomized placebo‐controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)

Sung Yong Cho(SNUH SMG-SNU Boramae Medical Center), Seung‐June Oh(Seoul National University Hospital), Jang Hwan Kim(Yonsei University), Min Soo Choo(Seoul National University), Sangchul Lee(Seoul National University Bundang Hospital), Seong Jin Jeong(Seoul National University Bundang Hospital), Seong Ho Lee(Hallym University)
Neurourology and Urodynamics
January 1, 2021
Cited by 37


Related Papers